Figures computed from official regulatory filings — .
Analysttarget 5 USD (+41567%) · consensus 3/5 · 0 buy · 1 hold · 0 sell
Ownershipinsiders 0% · institutions 11% · short 7.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for TREVENA INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
28 buys13 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Bourdow Carrie L. | Other | $419 | SEC | ||
| Shin Barry |
| Other |
| $191.1 |
| SEC |
| Bourdow Carrie L. | Other | $1.6K | SEC |
| Demitrack Mark | Other | $782 | SEC |
| Shin Barry | Other | $25 | SEC |
| Demitrack Mark | Other | $211.7 | SEC |
| Bourdow Carrie L. | Other | $419 | SEC |
| Bourdow Carrie L. | Other | $210.2 | SEC |
| Demitrack Mark | Other | $29.4 | SEC |
| Demitrack Mark | Other | $211.7 | SEC |
| Demitrack Mark | Other | $66.2 | SEC |
| Shin Barry | Other | $717.4 | SEC |
| Shin Barry | Other | $191.1 | SEC |
| Shin Barry | Other | $60.3 | SEC |
| Bourdow Carrie L. | Other | $79.4 | SEC |
| Shin Barry | Other | $17.9 | SEC |
| Yoder Robert T | Other | $2.9K | SEC |
| Braunstein Scott | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Phillips Anne M. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Johnson Marvin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yanni Barbara | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CORRIGAN MARK | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nunn Jason Raleigh | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bourdow Carrie L. | Award | $61K | Unusual size | SEC |
| Yoder Robert T | Award | $15.3K | SEC |